FDA Device Intelligence
HomeKAMIYA BIOMEDICAL COMPANY, LLC › K-ASSAY® IgG Reagent

K-ASSAY® IgG Reagent

KAMIYA BIOMEDICAL COMPANY, LLC · Model KAI-014 · UDI-DI 00816426020108

DEW Prescription
1
510(k) clearances
71
Adverse events
4
Recalls
25
Facilities

Description

For the quantitative determination of human IgG in serum by immunoturbidimetric assay.

Recalls

DateFirmReason
2024-07-31Beckman Coulter Inc.Firm identified two lots of reagents that are not meeting the sensitivity statement in the IFU
2018-05-16Abbott Laboratories, IncAn update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products.
2010-06-28Beckman Coulter Inc.The recall was initiated after Beckman Coulter Inc. confirmed reports of high recovery of immunoglobulin A (IgA) in proficiency surveys or patient samples using Synchron Ig-A reage
2003-06-06Beckman Coulter Inclow level IgM serum sample results may be suppressed and an error code generated when using affected lots. Error codes are seen as E60 or E66.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.